Qingyi Ma Selected Research

2-f)quinazoline-1,3-diamine N3- cyclopropyl- 7- ((4- (1- methylethyl)phenyl)methyl)- 7H- pyrrolo(3

5/2013	Role of SCH79797 in maintaining vascular integrity in rat model of subarachnoid hemorrhage.
2/2013	PAR-1 antagonist SCH79797 ameliorates apoptosis following surgical brain injury through inhibition of ASK1-JNK in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qingyi Ma Research Topics

Disease

20	Brain Injuries (Brain Injury) 08/2021 - 02/2011
13	Brain Edema (Cerebral Edema) 08/2021 - 03/2010
7	Cerebral Hemorrhage 02/2014 - 03/2010
6	Hypoxia (Hypoxemia) 01/2020 - 02/2010
5	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2015 - 02/2012
3	Brain Infarction 01/2021 - 05/2016
3	Cognitive Dysfunction 01/2021 - 01/2013
3	Ischemic Stroke 01/2019 - 08/2011
3	Ischemia 02/2016 - 03/2011
3	Edema (Dropsy) 01/2015 - 12/2011
3	Hemorrhage 02/2013 - 06/2011
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 01/2013
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2020 - 08/2018
2	Fetal Hypoxia 01/2020 - 01/2016
2	Infarction (Infarctions) 08/2018 - 06/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 01/2013
2	Inflammation (Inflammations) 02/2014 - 03/2010
2	Hemorrhagic Stroke 02/2012 - 08/2011
1	Vascular System Injuries 08/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2019
1	Gliosis 01/2019
1	Body Weight (Weight, Body) 01/2017
1	Reperfusion Injury 02/2016
1	Neuroinflammatory Diseases 10/2013
1	Neurologic Manifestations (Neurological Manifestations) 05/2013
1	Amyloidosis 01/2013
1	Amyloid angiopathy 01/2013
1	Intracranial Vasospasm 12/2012
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2011

Drug/Important Bio-Agent (IBA)

5	Neuroprotective AgentsIBA 01/2021 - 03/2010
5	Proteins (Proteins, Gene)FDA Link 08/2019 - 01/2013
5	Small Interfering RNA (siRNA)IBA 08/2018 - 02/2012
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2013
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019 - 02/2016
3	Thrombin FDA Link 05/2013 - 12/2011
3	Collagenases (Collagenase)FDA Link 05/2013 - 01/2011
2	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 08/2021 - 01/2018
2	Immunoglobulin G (IgG)IBA 08/2021 - 06/2017
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 08/2019 - 06/2011
2	Decitabine FDA Link 01/2017 - 02/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 02/2010
2	EnzymesIBA 02/2014 - 06/2011
2	InflammasomesIBA 02/2014 - 10/2013
2	salicylhydroxamic acid (SHAM)IBA 12/2013 - 06/2011
2	HydrogenIBA 05/2013 - 01/2011
2	2-f)quinazoline-1,3-diamine N3- cyclopropyl- 7- ((4- (1- methylethyl)phenyl)methyl)- 7H- pyrrolo(3IBA 05/2013 - 02/2013
2	Isoflurane FDA LinkGeneric 08/2011 - 06/2011
2	OsteopontinIBA 03/2011 - 02/2011
1	RNA (Ribonucleic Acid)IBA 01/2021
1	DioxygenasesIBA 01/2021
1	ChromatinIBA 01/2021
1	CytokinesIBA 01/2021
1	Oxygen (Dioxygen)IBA 08/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2019
1	CaspasesIBA 08/2019
1	sulofenur (ISCU)IBA 08/2019
1	SulfurIBA 08/2019
1	IronIBA 08/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2018
1	4-nitrophenylphosphorylcholine (NPPC)IBA 01/2018
1	Natriuretic PeptidesIBA 01/2018
1	locked nucleic acidIBA 06/2017
1	OligonucleotidesIBA 06/2017
1	A-Form DNA (A-DNA)IBA 01/2017
1	MethyltransferasesIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 02/2016
1	Apolipoprotein E4IBA 01/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2015
1	ImmunosorbentsIBA 02/2014
1	Peroxidase (Myeloperoxidase)IBA 02/2014
1	Purinergic P2X7 ReceptorsIBA 12/2013
1	coomassie Brilliant BlueIBA 12/2013
1	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 12/2013
1	p38 Mitogen-Activated Protein KinasesIBA 12/2013
1	Tryptases (Tryptase)IBA 05/2013
1	Phosphotransferases (Kinase)IBA 05/2013
1	argatroban (MPQA)FDA Link 02/2013
1	PAR-1 ReceptorIBA 02/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Transcription Factor CHOPIBA 12/2012
1	CateninsIBA 04/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2012
1	Y 27632IBA 04/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2012
1	Vincristine (Oncovin)FDA LinkGeneric 02/2012
1	Prednisone (Sone)FDA LinkGeneric 02/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2012
1	Evans Blue (Blue, Evans)FDA Link 12/2011
1	Anesthetics (Anesthetic Agents)IBA 08/2011
1	Blood Glucose (Blood Sugar)IBA 06/2011
1	Superoxide DismutaseIBA 06/2011
1	CatalaseIBA 06/2011

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2011
1	Neurosurgical Procedures 02/2013
1	Aftercare (After-Treatment) 06/2011